:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/popsci/popsci-rssapp-ophthalmologytimes-com-078b2e37/074517c751b999969fd65e1247d03db5_wm.png)
PRIMAvera study: Central vision improvement with subretinal implant | Ophthalmology Times - Clinical Insights for Eye Specialists
Summary: A new study called PRIMAvera tested a tiny, wireless eye implant for people with severe vision loss from age-related macular degeneration (AMD). AMD destroys cells in the center of the eye, making it hard to read or see faces.
The new PRIMA system uses special glasses with a camera. These glasses send infrared light to a tiny microchip placed under the retina. This chip turns the light into electrical signals, doing the job of the eye's dead cells. In the trial, 81% of patients had much better vision after one year, allowing them to do everyday tasks like reading and writing again.
Source: Ophthalmology Times URL: ophthalmologytimes.com/view/primavera-study-central-vision-improvement-with-subretinal-implant (opens in new tab)
Tags
Macular Degeneration
Disease Progression
Geographic Atrophy
Disease
Atrophy
Therapies, Investigational